Activation of GPR30 stimulates GTP-binding of Gαi1 protein to sustain activation of Erk1/2 in inhibition of prostate cancer cell growth and modulates metastatic properties

Autor: Lau, Kin-Mang, Ma, Fanny Man-Ting, Xia, Jenny Tian, Chan, Queeny Kwan Yi, Ng, Chi-Fai, To, Ka-Fai

Publikováno v: In Experimental Cell Research 1 January 2017 350(1):199-209

MEDULLOBLASTOMA

Autor: Morfouace, Marie, Shelat, Anang, Megan, Jacus, Freeman, Burgess B, Robinson, Sarah, Throm, Stacy, Olson, James M, Li, Xiao-Nan, Guy, Kip R, Robinson, Giles, Stewart, Clinton, Gajjar, Amar, Roussel, Martine, Sirachainan, Nongnuch, Pakakasama, Samart, Anurathapan, Usanarat, Hansasuta, Ake, Dhanachai, Mantana, Khongkhatithum, Chaiyos, Hongeng, Suradej, Feroze, Abdullah, Lee, Kyu-Sun, Gholamin, Sharareh, Wu, Zhihao, Lu, Bingwei, Mitra, Siddhartha, Cheshier, Samuel, Northcott, Paul, Lee, Catherine, Zichner, Thomas, Lichter, Peter, Korbel, Jan, Wechsler-Reya, Robert, Pfister, Stefan, Project, ICGC PedBrain Tumor, Li, Kay Ka-Wai, Xia, Tian, Ma, Fanny Man Ting, Zhang, Rong, Zhou, Liangfu, Lau, Kin-Mang, Ng, Ho-Keung, Lafay-Cousin, Lucie, Chi, Susan, Madden, Jennifer, Smith, Amy, Wells, Elisabeth, Owens, Emily, Strother, Douglas, Foreman, Nicholas, Packer, Roger, Bouffet, Eric, Wataya, Takafumi, Peacock, John, Taylor, Michael D, Ivanov, Delyan, Garnett, Martin, Parker, Terry, Alexander, Cameron, Meijer, Lisethe, Grundy, Richard, Gellert, Paul, Ashford, Marianne, Walker, David, Hayase, Tomomi, Kawahara, Yuta, Yagi, Masaki, Minami, Takaomi, Kanai, Nobuyuki, Yamaguchi, Takehiko, Gomi, Akira, Morimoto, Akira, Hill, Rebecca, Kuijper, Sanne, Lindsey, Janet, Schwalbe, Ed, Barker, Karen, Boult, Jessica, Williamson, Daniel, Ahmad, Zai, Hallsworth, Albert, Ryan, Sarra, Poon, Evon, Robinson, Simon, Ruddle, Ruth, Raynaud, Florence, Howell, Louise, Kwok, Colin, Joshi, Abhijit, Nicholson, Sarah Leigh, Crosier, Stephen, Wharton, Stephen, Robson, Keith, Michalski, Antony, Hargrave, Darren, Jacques, Thomas, Pizer, Barry, Bailey, Simon, Swartling, Fredrik, Petrie, Kevin

Publikováno v: Neuro-oncology, vol 16, iss Suppl 1

BACKGROUND: LMD in children with recurrent medulloblastoma and other PNETs carries a poor prognosis and novel therapies are urgently needed to improve disease control. Somatostatin receptor-2 (SSR-2)is overexpressed in medulloblastoma and other centr

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::79fae5693b9e07e1e3a159df648147c0
https://escholarship.org/uc/item/5897656z

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.